Management of Urinary Incontinence Following Radical Prostatectomy: Challenges and Solutions
Pietro Castellan,Simone Ferretti,Giulio Litterio,Michele Marchioni,Luigi Schips
DOI: https://doi.org/10.2147/TCRM.S283305
2023-01-15
Therapeutics and Clinical Risk Management
Abstract:Pietro Castellan, 1 Simone Ferretti, 2 Giulio Litterio, 2 Michele Marchioni, 1, 2 Luigi Schips 1, 2 1 Department of Urology, ASL02 Abruzzo, Chieti, Italy; 2 Department of Medical, Oral and Biotechnological Sciences, G. d'Annunzio University of Chieti, Urology Unit, Chieti, Italy Correspondence: Simone Ferretti, Department of Medical, Oral and Biotechnological Sciences, G. d'Annunzio University of Chieti, Urology Unit, Chieti, Italy, Tel +393278733805, Fax +390871357756, Email Urinary incontinence is a common and debilitating problem in patients undergoing radical prostatectomy. Current methods developed to treat urinary incontinence include conservative treatments, such as lifestyle education, pelvic muscle floor training, pharmacotherapy, and surgical treatments, such as bulking agents use, artificial urinary sphincter implants, retrourethral transobturator slings, and adjustable male sling system. Pelvic floor muscle exercise is the most common management to improve the strength of striated muscles of the pelvic floor to try to recover the sphincter weakness. Antimuscarinic drugs, phosphodiesterase inhibitors, duloxetine, and a-adrenergic drugs have been proposed as medical treatments for urinary incontinence after radical prostatectomy. Development of new surgical techniques, new surgical tools and materials, such as male slings, has provided an improvement of outcomes after UI surgery. Such improvement is still ongoing, and the uptake of new devices might lead to even better outcomes after UI surgery. Keywords: urinary incontinence, radical prostatectomy, pelvic muscle floor exercise, artificial urinary sphincter, male slings, anticholinergic agents, PDE5 inhibitors, duloxetine Prostate cancer (PCa) is the most common male cancer and one of the major causes of cancer-related death. The earlier diagnosis and the development of new effective treatments have improved PCa prognosis. 1 Radical prostatectomy (RP) and radiotherapy are the first-line treatment for localized PCa, with nearby active surveillance in specific patients. 2,3 Most studies have shown similar oncological and functional outcomes after open versus RARP. 4,5 However, RARP warrants 3D vision of operation field allowing performance of precise and accurate surgery. Consequently, a better preservation of anatomical structure is possible, alongside a lower risk of complications. 6 Unfortunately, even after RARP, up to 31% of patients might suffer UI. 6 Causes of postoperative urinary incontinence (UI) are extensive dissection during surgery with injuries to the internal sphincter, to the external rhabdosphincter, to the supporting structures of the urethra, 7 or to the neurovascular bundle, 8 and even the development of post-operative fibrosis. Conservative and surgical treatments were developed for UI treatment. Conservative strategies include lifestyle education, pelvic muscle floor training (PMFT), and pharmacotherapy. Surgical treatments include bulking agents use, artificial urinary sphincter implants, retrourethral transobturator slings, and adjustable male sling systems. 9,10 We aim to provide an overview of current evidence about male UI treatments after prostatectomy. The International Continence Society (ICS) defines UI as a condition that occurs when there is involuntary loss of urine, 11 so demonstrable as to create a hygienic or social problem. Always ICS defines overactive bladder (OAB) as a symptomatic diagnosis characterized by urinary urgency, increased daytime frequency and/or nocturia, with or without urinary incontinence, in the absence of urinary tract infection or other detectable disease. 12 Detrusor overactivity (DO) is an urodynamic diagnosis in patients with lower urinary tract symptoms when detrusor muscle contracts during filling cystometry. 12 Almost 30% of OAB do not have DO at urodynamic study. 13 Continence is normally determined by the combination of the detrusor muscle, the intrinsic sphincter, the rhabdosphincter, and the pubourethral ligaments. 14,15 For normal urinary function, the autonomic and voluntary nervous systems must be intact, and urinary tract muscle must be functional. RP involves the removal of the proximal urethral sphincter and pubourethral suspensory ligaments. Consequently, the rhabdosphincter becomes the main structure responsible for the urinary continence. 16 In addition, damage to the neurovascular bundle of the rhabdosphincter might affect continence recovery. 17 Such considerations might explain occurrence of SUI after RP. Intrinsic sphincter deficiency (ISD) is the most commonly urodynamic finding observed after radical prostatectomy (67–92 -Abstract Truncated-
health care sciences & services